Neuroblastoma

Showing NaN - NaN of 61

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

Recruiting
  • Colorectal Carcinoma
  • +21 more
  • Dual X-ray Absorptiometry
  • +2 more
  • Birmingham, Alabama
  • +18 more
Jan 30, 2023

Neuroblastoma Trial in United States (DFMO)

Active, not recruiting
  • Neuroblastoma
  • Phoenix, Arizona
  • +21 more
Jan 25, 2023

Neuroblastoma Trial in Houston (GINAKIT Cells, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Neuroblastoma
  • GINAKIT Cells
  • +2 more
  • Houston, Texas
    Texas Children's Hospital
Jan 18, 2023

Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Neuroblastoma Trial in Worldwide (Idasanutlin, Venetoclax,

Recruiting
  • Acute Myeloid Leukemia (AML)
  • +3 more
  • Phoenix, Arizona
  • +19 more
Jan 18, 2023

Neuroblastoma Trial in Houston (iC9-GD2 T Cells - frozen, iC9-GD2 T Cells - fresh, Cytoxan)

Active, not recruiting
  • Neuroblastoma
  • iC9-GD2 T Cells - frozen
  • +5 more
  • Houston, Texas
  • +1 more
Jan 4, 2023

Neuroblastoma, Medulloblastoma Trial in United States (Nifurtimox, Cyclophosphamide, Topotecan)

Completed
  • Neuroblastoma
  • Medulloblastoma
  • San Diego, California
  • +14 more
Dec 28, 2022

Refractory Cancer, Refractory Tumor, Cancer Pediatric Trial in United States (9-ING-41, Irinotecan, Temozolomide)

Recruiting
  • Refractory Cancer
  • +10 more
  • Aurora, Colorado
  • +7 more
Dec 31, 2022

Ganglioneuroblastoma, Neuroblastoma Trial in Canada, Puerto Rico, United States (procedure, drug, biological, radiation)

Recruiting
  • Ganglioneuroblastoma
  • Neuroblastoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +18 more
  • Birmingham, Alabama
  • +158 more
Sep 14, 2022

Neuroblastoma Trial in Worldwide (GM-CSF + Naxitamab)

Recruiting
  • Neuroblastoma
  • GM-CSF + Naxitamab
  • Gainesville, Florida
  • +22 more
Aug 29, 2022

Ewing Sarcoma, Solid Tumors, Rhabdoid Tumor Trial in Worldwide (Palbociclib, Temozolomide, Irinotecan)

Recruiting
  • Ewing Sarcoma
  • +6 more
  • Birmingham, Alabama
  • +83 more
Aug 19, 2022

Neuroblastoma Trial in Worldwide (LY3295668 Erbumine, Topotecan, Cyclophosphamide)

Active, not recruiting
  • Neuroblastoma
  • LY3295668 Erbumine
  • +2 more
  • San Francisco, California
  • +21 more
Aug 17, 2022

Ganglioneuroblastoma, Nodular, Neuroblastoma Trial in Worldwide (Dinutuximab, Irinotecan, Isotretinoin)

Active, not recruiting
  • Ganglioneuroblastoma, Nodular
  • Neuroblastoma
  • Dinutuximab
  • +4 more
  • Mesa, Arizona
  • +77 more
Aug 17, 2022

Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Worldwide (Carboplatin,

Recruiting
  • Ganglioneuroblastoma
  • +3 more
  • Birmingham, Alabama
  • +219 more
Aug 17, 2022

Recurrent or Refractory Solid Tumors, Ewing Sarcoma, Rhabdomyosarcoma Trial in United States (MM-398 (Irinotecan Sucrosofate

Recruiting
  • Recurrent or Refractory Solid Tumors
  • +4 more
  • MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide
  • Cincinnati, Ohio
  • +5 more
Mar 17, 2022

Neuroblastoma Trial in Houston (Neuroblastoma Vaccine (unmodified SKNLP, with gene-modified SJNB-JF-IL2 and SJNB-JF-LTN

Active, not recruiting
  • Neuroblastoma
  • Neuroblastoma Vaccine (unmodified SKNLP, with gene-modified SJNB-JF-IL2 and SJNB-JF-LTN neuroblastoma cells
  • Cytoxan
  • Houston, Texas
    Texas Children's Hospital
Mar 25, 2022

Neuroblastoma Trial in Houston (SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 1 SKNLP, SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 2

Active, not recruiting
  • Neuroblastoma
  • SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 1 SKNLP
  • SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 2 SKNLP
  • Houston, Texas
    Texas Children's Hospital
Mar 3, 2022

Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma Trial in United States (Enoblituzumab)

Completed
  • Neuroblastoma
  • +5 more
  • Palo Alto, California
  • +5 more
Feb 4, 2022

Neuroblastoma Trial in Houston (EBV specific CTLs)

Active, not recruiting
  • Neuroblastoma
  • EBV specific CTLs
  • Houston, Texas
    Texas Children's Hospital
Feb 2, 2022

Neuroblastoma, Neuroectodermal Tumors, Tumors Trial in United States (131I-MIBG, 131-MIBG + Vorinostat)

Recruiting
  • Neuroblastoma
  • +2 more
  • San Francisco, California
  • +15 more
Jan 7, 2022

Neuroblastoma, CNS Metastases, Leptomeningeal Metastases Trial in Worldwide (131I-omburtamab)

Recruiting
  • Neuroblastoma
  • +2 more
  • 131I-omburtamab
  • Los Angeles, California
  • +11 more
Dec 17, 2021

Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor Trial in Australia, Canada, United States (CLR 131)

Recruiting
  • Pediatric Solid Tumor
  • +7 more
  • CLR 131
  • Palo Alto, California
  • +6 more
Nov 30, 2021

Neuroblastoma Trial in Worldwide (carboplatin, cyclophosphamide, doxorubicin HCl)

Completed
  • Neuroblastoma
  • Birmingham, Alabama
  • +188 more
Jul 1, 2021

Osteosarcoma, Neuroblastoma Trial in Houston (genetic, biological, drug)

Active, not recruiting
  • Osteosarcoma
  • Neuroblastoma
  • GD2 T cells
  • +3 more
  • Houston, Texas
  • +1 more
Apr 16, 2021

Neuroblastoma Trial in United States (DFMO)

Active, not recruiting
  • Neuroblastoma
  • Phoenix, Arizona
  • +17 more
Nov 16, 2020